Rhythm Pharmaceuticals, Inc. (RYTM)
113.34
+5.54
(+5.14%)
USD |
NASDAQ |
Jan 14, 16:00
114.00
+0.66
(+0.58%)
Pre-Market: 09:18
Rhythm Pharmaceuticals SG&A Expense (TTM): 175.59M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 10.39B |
| Gilead Sciences, Inc. | 5.886B |
| Johnson & Johnson | 23.38B |
| ACADIA Pharmaceuticals, Inc. | 523.36M |
| Geron Corp. | 160.96M |